[Congressional Record Volume 169, Number 202 (Thursday, December 7, 2023)]
[Senate]
[Pages S5847-S5849]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
WORLD AIDS DAY 2023
Mr. CARDIN. Mr. President, this past Friday, December 1, we marked
the 35th anniversary of World AIDS Day. World AIDS Day serves as a
reminder of the global struggle to end AIDS, an opportunity to honor
those we have lost while supporting those who are living with or at
risk of the HIV virus, and as a unifying call to continue working
toward a day when HIV is no longer stigmatized or a public health
threat.
Thirty-five years ago this year, World AIDS Day was established,
marking the first international day for global health. Since then,
World AIDS Day has adopted targeted themes to raise awareness and
encourage international cooperation. This year's theme in the United
States, ``Remember and Commit,'' focuses on paying tribute to those we
have lost to HIV/AIDS, emphasizing our collective responsibility to
act. Through remembrance, we draw strength and determination to
redouble our efforts in fighting this global crisis and support those
living with HIV both here and abroad. The 2023 campaign reminds us that
each one of us can make a difference while promoting the importance of
compassion, empathy, and solidarity in the face of adversity. And it
reminds us that as citizens of the world, the United States must
continue to provide a helping hand to countries less fortunate than
ours in bringing an end to the AIDS pandemic.
Since the first cases of AIDS were reported in the U.S. in June 1981,
more than 700,000 people in the U.S. have died from HIV-related
illnesses. In 2021, over 36,000 people were diagnosed with HIV in the
U.S., and more than 1.1 million people in our country are currently
living with this virus, with
[[Page S5848]]
many more at risk of HIV infection. In 2021, there were 32,100
estimated new HIV infections in the U.S. My home State of Maryland is
not immune; during 2022, 751 Marylanders over 13 years old were newly
diagnosed with HIV, and over 31,000 Marylanders were living with the
disease.
Recent data show that minority populations continue to remain
disproportionately affected by HIV/AIDS. In 2021, Black Americans
accounted for 40 percent of HIV diagnoses, while Hispanic/Latino
Americans accounted for 29 percent of HIV diagnoses. We must work
harder to address persistent health inequities and end the disparities
in access to prevention, care, and treatment.
World AIDS Day reminds us that HIV is not just a medical issue. It is
a human rights issue. Criminalization, discrimination, and social
stigmas continue to impact the most vulnerable populations across the
globe. In sub-Saharan Africa, where the United States proudly invests
the majority of our global HIV spending, violence and discrimination
against women and girls continues to fuel the epidemic. Children who
are orphaned or otherwise affected by HIV face a range of challenges
from child labor, to the worst forms of exploitation.
Fortunately, thanks to scientific advances, the U.S. Food and Drug
Administration--FDA--has now approved more than 30 medicines to treat
HIV infection, including the new class of antiretroviral drugs, which
have transformed HIV from a death sentence to a chronic but manageable
disease. They help extend and stabilize the lives of those living with
HIV while also dramatically reducing the risk of HIV transmission. This
makes it all the more imperative that all people who need HIV treatment
have access to it.
We are fortunate to have premier scientific research institutes
within my home State of Maryland working together to combat this deadly
virus, including the National Institutes of Health--NIH--the Walter
Reed Army Institute of Infectious Disease Research, the Institute of
Human Virology at the University of Maryland, and Johns Hopkins
University. Not only have these organizations substantially led
scientific advancements with respect to HIV/AIDS, they have also played
an important role in reducing the number of new cases among Marylanders
and affording those living with HIV the opportunity to continue living
full lives.
As a result, Maryland has reached significant milestones in reducing
HIV case numbers; my State went from ranking seventh among all the U.S.
States and territories to 12th in 2 years. Baltimore City, Montgomery
County, and Prince George's County have been participants in the
Department of Health and Human Services--HHS--Ending the HIV Epidemic
in the U.S. Program, which is working to reduce new HIV transmissions
by 75 percent by 2025 and by 90 percent by 2030. This multi-year
program will infuse 48 counties; Washington, DC; San Juan, PR; and
seven States that have a substantial rural HIV burden with the
additional expertise, technology, and resources they need to reduce
transmission. Public health initiatives the Maryland Department of
Health has implemented--including safer-sex education programs, free
HIV self-tests, condom distribution, and access to prophylactic
medication--have been instrumental in reducing new infections.
Additionally, city and county needle exchange programs have broadened
efforts to reduce the circulation of used syringes, provide testing for
infectious diseases such as HIV, and extend resources for the treatment
of substance use disorders.
Thanks to the Affordable Care Act--ACA--Americans diagnosed with HIV
or at risk of transmission have more meaningful access to healthcare
coverage and health insurance. Today, Americans cannot be dropped or
denied coverage because of preexisting health conditions such as
asthma, cancer, HIV, or COVID-19. The ACA also gives States the option
to expand Medicaid, the largest payer for those who need HIV treatment
in the country, and so far, 41 States have expanded Medicaid coverage.
I look forward to seeing the remaining States join this list.
The ACA has also established new standards and essential benefits
that certain health plans must cover. Benefits such as prescription
drug services, hospital inpatient care, lab tests, HIV screening,
preexposure prophylaxis or PrEP, and other preventive services aim to
preserve the health of those with HIV while mitigating further
transmission. Under the ACA, most health insurance plans must provide
preventive services, including HIV testing for those aged 15 to 65, as
well as PrEP for HIV-negative adults at high risk of HIV infection. I
am proud to have served as a cosponsor of the PrEP Access and Coverage
Act, which would expand access to PrEP and work to reduce the existing
disparities in access. Legislation like this is especially important in
light of recent threats to PrEP access, such as a Texas judge's ruling
in Braidwood Management v. Becerra, a decision which has the potential
to result in thousands of unnecessary HIV infections.
I commend the Biden-Harris administration for publishing the National
HIV/AIDS Strategy for the United States (2022-2025) to provide a
roadmap to accelerate efforts to end the HIV epidemic in our country by
2030. These are bold targets facilitated by the White House's Office of
National AIDS Policy, ONAP. The Strategy builds on our country's
progress and lessons learned from the prior national strategies and
seeks to leverage new tools and opportunities to address the challenges
that remain. I share President Biden's determination to address the
disproportionate impact of the epidemic on marginalized populations
like the LGBTQI+ community and racial and ethnic minorities.
We must remember, however, that HIV remains a grave public health
challenge around the world. In 2022, 39 million people lived with HIV
globally. Last year, roughly 630,000 people died from AIDS-related
illnesses. Only 57 percent of children aged 14 and younger had access
to treatment in 2022, compared to 77 percent of those aged 15 and over.
We must redouble our efforts to close this gap and guarantee lifesaving
HIV treatment to all who need it and to prevent more HIV infections.
And it can be done.
This year, President Biden commemorated the 20th anniversary of the
U.S. President's Emergency Plan for AIDS Relief--PEPFAR--honoring the
25 million lives that have been saved worldwide in the fight to end
HIV/AIDS as a public health crisis. Since its inception in 2003, the
PEPFAR program has changed the trajectory of the HIV epidemic around
the globe, representing an extraordinary commitment to global health,
aiming to prevent, diagnose, and treat HIV infections. Over nearly 20
years, five mission babies have been born AIDS free, 7 million orphans
have been supported, and 20 million people are on lifesaving treatment
medications. PEPFAR has also demonstrated the value of strong health
systems in managing and anticipating other pandemics. Much of the
staff, infrastructure, and technology that was developed through PEPFAR
proved instrumental in the COVID-19 response in countries that would
otherwise not have the capacity to deliver treatment and vaccines. But
we have not crossed the finish line yet. The next 5 years are critical
to meet the goal of ending the global HIV/AIDS epidemic by 2030. The
U.S. must continue to show global health leadership and facilitate
cooperation with our foreign partners and allies.
We must continue to invest in the communities and local leaders that
know their own health needs best. All people, regardless of age, sex,
gender identity, sexual orientation, race, ethnicity, religion,
disability, geographic location, or socioeconomic circumstance, should
have access to prevention, treatment, and care. International partners,
academic partners, faith-based organizations, and civil society are
counting on us to continue our support for their long-held efforts to
ending AIDS. This is why I call on my colleagues on both sides of the
aisle to once again step forward in faith and courage and join together
to secure PEPFAR's reauthorization.
Most importantly, I want to recognize those living with HIV/AIDS
across the globe. Your demand for dignity and access to healthcare has
shown us what is possible when the world works together to fight a
public health scourge, and in accordance with that spirit, we will
prevail in doing so. We must recommit ourselves to continuing this
[[Page S5849]]
fight because success is within our reach.
____________________